Gihani Wijewickrama

Gihani Wijewickrama is a Principal Scientist in CMC Analytical Development at FibroGen, Inc., with experience since September 2016, focusing on physicochemical characterization of therapeutic antibodies using platforms such as LCMS, CEX, and SEC. Prior to this role, Gihani served as a Senior Scientist at Genentech South San Francisco and Eurofins Lancaster Laboratory, supporting late-stage therapeutic antibodies through analytical method development and validation, as well as process characterization and validation. Additional experience includes working as a BioAnalytical Scientist at Amgen, providing analytical support for therapeutic antibody characterization, and holding research positions at the University of California, Los Angeles, and the University of Illinois Chicago. Gihani holds a Ph.D. in Chemistry/Biochemistry from the University of Illinois Chicago and a Bachelor of Science with Honors in Chemistry from the University of Kelaniya, Sri Lanka.